Annalisa Lattanzi

Statistics

Publications

Citations

915

H-Index

Active since

2009

Affiliations

The San Raffaele Telethon Institute for Gene Therapy(Current)

Stanford University

University of Perugia

Genethon (France)

Inserm

Annalisa Lattanzi is an author at The San Raffaele Telethon Institute for Gene Therapy specializing in gene therapy, life sciences, and therapeutic genome editing.

ORCID

Publications per year

2009–2023

Publications

Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus

Chiara Antoniani, Vasco Meneghini, Annalisa Lattanzi et al. · Blood · 2018 · 187 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease

Annalisa Lattanzi, Joab Camarena, Premanjali Lahiri et al. · Science Translational Medicine · 2021 · 160 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements

Annalisa Lattanzi, Vasco Meneghini, Giulia Pavani et al. · Molecular Therapy · 2018 · 132 citations · Full text

Life Sciences, Genetics, Hematology +17

Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models

Annalisa Lattanzi, Margherita Neri, Claudio Maderna et al. · Human Molecular Genetics · 2010 · 80 citations

Medicine, Neurobiology, Neuroscience +17

Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy

Annalisa Lattanzi, Camilla Salvagno, Claudio Maderna et al. · Human Molecular Genetics · 2014 · 58 citations · Full text

Medicine, Neurology, Neuroscience +12

1–5 of 13